These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Enzyme therapy in treatment of mastopathy. A randomized double-blind clinical study]. Rammer E; Friedrich F Wien Klin Wochenschr; 1996; 108(6):180-3. PubMed ID: 8650928 [TBL] [Abstract][Full Text] [Related]
5. [Experiences with a special consultation for breast diseases]. Kasch R; Meissner J; Barten G Zentralbl Gynakol; 1986; 108(6):347-53. PubMed ID: 3521150 [TBL] [Abstract][Full Text] [Related]
6. Current status of hormonal therapy of fibrocystic breast disease. Dogliotti L; Fioretti P; Melis GB; Mussa A; Angeli A Ann N Y Acad Sci; 1986; 464():350-63. PubMed ID: 3089096 [No Abstract] [Full Text] [Related]
7. [Treatment of fibrocystic breast disease with lisuride]. López Rosales C; Romero Espinosa RE; Juárez Vazquez J Ginecol Obstet Mex; 1991 Dec; 59():358-61. PubMed ID: 1819543 [TBL] [Abstract][Full Text] [Related]
8. [The Depo-Provera treatment of mastopathy patients]. Khomasuridze AG; Manusharova RA Lik Sprava; 1993; (10-12):104-6. PubMed ID: 8030291 [TBL] [Abstract][Full Text] [Related]
9. [Results of chronic treatment with bromocriptine in patients with fibrocystic mastopathy]. Ablanedo J; Canales ES Arch Invest Med (Mex); 1988; 19(3):225-9. PubMed ID: 3242433 [No Abstract] [Full Text] [Related]
10. [Treatment of mastodynia and mastopathy using Mastodynon]. Roeder D Med Welt; 1976 Mar; 27(12):591-2. PubMed ID: 772357 [No Abstract] [Full Text] [Related]
11. [Experiences with mastodynon in the treatment of the premenstrual syndrome]. Roeder D Fortschr Med; 1977 May; 95(17):1175-8. PubMed ID: 558142 [TBL] [Abstract][Full Text] [Related]
12. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154). Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107 [TBL] [Abstract][Full Text] [Related]
13. [Assessment of selected hormonal parameters in patients with mastopathy in postmenopausal period]. Mizia-Stec K; Zych F; Widala E Ginekol Pol; 1998 Feb; 69(2):56-61. PubMed ID: 9591381 [TBL] [Abstract][Full Text] [Related]
14. [Danazol for treatment of fibrocystic mastopathy]. von Fallois J; Etterli-Billenkamp U; Schindler EM; Schindler AE Zentralbl Gynakol; 1995; 117(9):457-65. PubMed ID: 7483879 [TBL] [Abstract][Full Text] [Related]
15. [Mastodynia and fibrocystic disease of the breast]. Pons JY J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):129. PubMed ID: 3584864 [No Abstract] [Full Text] [Related]
16. [Endocrinology of mastopathy and small breast cancer]. Huber J; Vytiska E Wien Med Wochenschr; 1987 Mar; 137(5-6):116-9. PubMed ID: 3037805 [TBL] [Abstract][Full Text] [Related]
17. [Clinical experience with danazol treatment of endometriosis and mastopathy]. Pavelka R; Schneider WH Wien Klin Wochenschr; 1981 Oct; 93(19):595-9. PubMed ID: 6798763 [TBL] [Abstract][Full Text] [Related]
18. [Danazol in treatment of cystic mastopathy]. Radivojevic K Wien Klin Wochenschr; 1991; 103(23):710-3. PubMed ID: 1792797 [TBL] [Abstract][Full Text] [Related]
20. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment]. van Bogaert LJ J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]